Detail
LncRNA Name | RAB11B-AS1 |
Synonyms | NA |
Region | GRCh38_19:8374373-8390685 Sequence |
Ensembl | ENSG00000269386 |
RefSeq | NR_038237 |
Circulating | ✘ |
Drug-resisitant | ✔ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✔ |
Cancer Name | osteosarcoma |
ICD-0-3 | M9180/3 |
Methods | qPCR, Western blot, etc. |
Sample | osteosarcoma tissues, cell lines (U2OS, Sao-2, MG-63, MNNG/HOS Cl#5[R-1059-D]) |
Expression Pattern | down-regulated |
Function Description | Here we discovered a novel lncRNA, RAB11B antisense RNA (RAB11B-AS1), which is markedly down-regulated in human osteosarcoma (OS) and associated with OS metastasis and poor prognosis. We find that reduction of RAB11B-AS1 significantly facilitates proliferation, migration and invasiveness and prevents apoptosis of OS cells and results in lower sensitivity to cisplatin in these cells.These data suggest that DNA hyper-methylation in the promoter region of lnc-RAB11B-AS1 might play an important role in down-regulation of lnc-RAB11B-AS1 in osteosarcoma. |
Pubmed ID | 29928484 |
Year | 2018 |
Title | Long non-coding RNA RAB11B-AS1 prevents osteosarcoma development and progression via its natural antisense transcript RAB11B. |
External Links |
Links for RAB11B-AS1 | GenBank HGNC lncrnadb Noncode |
Links for osteosarcoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.